Interv Akut Kardiol. 2009;8(4):182-185

Surgical treatment of aortic valve disease in the elderly

MUDr. Eva Koudelková CSc
Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

The number of elderly patients undergoing aortic valve surgery is increasing with the increase in life expectancy. The symptoms in septaand

octogenarians are often underestimated due to limited physical activity and they are reffered for surgery too late when advanced

calcifications of aortic valve as well as left ventricular systolic dysfunction in elderly men and diastolic dysfunction of the left ventricle in

elderly women are present. More than half of these patients require concomitant coronary artery bypass grafting and secondary mitral

insufficiency and pulmonary hypertension are also frequent. The prevalence of preoperative co-morbidities is also high of which renal

failure, obstructive pulmonary disease and peripheral vascular disease are especially important predictors of postoperative morbidity

and mortality.

Risk factors of operative mortality include prolonged cardiopulmonary bypass and cross-clamp time with the risk of acute renal or

multiorgan failure postoperatively. The results support a conservative approach to concomitant mitral surgery for secondary mitral

regurgitation in these patients undergoing aortic valve replacement. Additional procedure on aortic anulus and ascending aorta should

also be avoided to reduce ischemic times especially in octogenarians.

Elderly patients benefit from bioprosthetic valves because of avoiding anticoagulation with the associated risk of hemorrhage. However,

in patients with coexisting indications for systemic anticoagulation and in elderly women with severely hypertrophied left ventricle and

narrow aortic annulus mechanical valves are advantageous.

At the present time, aortic valve replacement in septa- and octogenarians has acceptable operative mortality and excellent functional

outcome with satisfactory long-term survival.

Keywords: aortic stenosis, aortic valve replacement, elderly.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koudelková E. Surgical treatment of aortic valve disease in the elderly. Interv Akut Kardiol. 2009;8(4):182-185.
Download citation

References

  1. Chukwuemeka A, Berger MA, Ivanov J, et al. Valve surgery in octogenarians: A safe option with good medium-term results. J Heart Valve Dis 2006; 15: 191-196. Go to PubMed...
  2. Adamíra M, Puštík P, Pirk J, a spol. Náhrada aortální chlopně u nemocných ve věku nad 80 let. Cor Vasa 2009; 51: 322-326. Go to original source...
  3. Asimakopoulos G, Edwards MB, Tailo KM. Aortic valve replacement in patiens 80 years of age and older: Survival and cause of death based of 1 100 cases: Collective results from the UK Heart Valve Registry. Circulation 1997; 96: 3403-3340. Go to original source... Go to PubMed...
  4. Vojáček J. První katetrizační implantace aortálních chlopní v České republice. Interv Akut Kardiol 2009; 8: 6-8.
  5. Carrol JD, Carrol EP, Feldeman T, et al. Sex. associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992; 86: 1099-1107. Go to original source... Go to PubMed...
  6. Morris JJ, Schaff HV, Mullany ChJ, et al. Gender differences in left ventricular functional response to aortic valve replacement. Circulation 1994; 90(part 2): II-183-II-189.
  7. Duncan AI, Lowe BS, Garcia MJ, et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg 2008; 85: 2030-2039. Go to original source... Go to PubMed...
  8. Aurigemma G, Battista S, Orsinelli D, et al. Abnormal left ventricular intracavitary flow acceleration in patiens undergoing aortic valve replacement for aortic stenosis: a marker for high postoperative morbidity and mortality. Circulation 1992; 86: 926-936. Go to original source... Go to PubMed...
  9. Ascione R, Caputo M, Gomes WJ, et al. Myocardial injury in hypertrophic hearts in patiens undergoing aortic valve surgery using cold and warm blood cardioplegia. Eur J Cardiothorac Surg 2002; 21: 440-446. Go to original source... Go to PubMed...
  10. Hess OM, Villari B, Krayenbuehl HP. Diastolic dysfunction in aortic stenosis. Circulation 1993; 87(suppl IV): IV-73-IV-76.
  11. Masoudi FA, Havranek EP, Smith G, et al. Gender, age and heart failure with preserved left vetricular systolic function. JACC 2003; 41: 217-223. Go to original source... Go to PubMed...
  12. Melby SJ, Zierer A, Kaiser SP, et al. Aortic valve replacement in octogenarians: Risk factors for early and late mortality. Ann Thorac Surg 2007; 83: 1651-1657. Go to original source... Go to PubMed...
  13. Urso S, Sadba R, Greco E, et al. One-hundered aortic valve replacements in octogenarians: Outcome and risk factors for early mortality. J Heart Valve Dis 2007; 16: 139-144. Go to PubMed...
  14. Ngaage DL, Cowen ME, Griffin S, et al. Are initial valve operations in octogenarians still high-risk in the current era? J Heart_Valve Dis 2008; 17: 227-232. Go to PubMed...
  15. Waisbren EC, Stevens LM Avery EG, et al. Changes in mitral regurgitation after replacement of the stenotic aortic valve. Ann Thorac Surg 2008, 86: 56-63. Go to original source... Go to PubMed...
  16. Iliuta l, Moldavan H, Filipescu D, et at. The role of pulmonary hypertension in increasing mortality in surgical aortic stenosis. Eur Heart J 2008; 29(Abstrakt suppl.): 143.
  17. Accola KD, Scott ML, Palmer GJ, et al. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis. J Heart Valve Dis 2008; 17: 355-365. Go to PubMed...
  18. Walter T, Rastan A, Falk V, et al. Patient prosthesis mismatch affects shot- and long term outcomes after aortic valve replacement. Eur J Cardiothorac Surg 2006; 30: 15-19. Go to original source... Go to PubMed...
  19. Vicchio M, DeSanto LS, Della Corte A, et al. Aortic valve replacement with 19-mm bileafflet prostheses in the elderly: Left ventricular mass regression and quality of life. J Heart Valve Dis 2008; 17: 216-221. Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.